By Jens Schou Christensen, Assembly and Packaging Head of Product Management, Stevanato Group, and Sebastian Berninger-Lund, Assembly and Packaging Automation Chief Designer, Stevanato Group
In this article, Jens Schou Christensen, Assembly and Packaging Head of Product Management, and Sebastian Berninger-Lund, Assembly and Packaging Automation Chief Designer, both at Stevanato Group, present the business case for the wider implementation of digitisation and the greater use of data to deliver assembly line improvements.
It is suggested that by as early as 2040, smart home products will be adopted almost universally across Europe. So far, the pace of uptake in new technologies has been meteoric – in 1998 just 9% of UK households had internet access, whereas today the figure is more than 90%.1
This surge in demand for technology has transcended into the manufacture and assembly of drug delivery devices. Today, data and the digitisation of assembly equipment work hand in hand to deliver competitive advantage to pharma partners in terms of product quality, continuous improvement, de-risking maintenance and change management and, critically for the near future, the ability to deliver unique identities and traceability for every assembled device.